Evidence map›Paper›PMID 35213962›Full record

ArticlePharmaceutics2022

Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria.

Emelie Öhnstedt, Hava Lofton Tomenius, Peter Frank, Stefan Roos, Evelina Vågesjö, Mia Phillipson

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05608187 (A Randomized, Double-Blind, Placebo-controlled, Parallel, Exploratory Phase 2a Study to Evaluate Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05608187 phase2terminatednot on this map

A Randomized, Double-Blind, Placebo-controlled, Parallel, Exploratory Phase 2a Study to Evaluate Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers

TypeinterventionalSponsorIlya PharmaRan2022 to 2024Enrolled1ConditionsWound Heal, Wound Healing Disturbance of, Wound Healing Disorder, Wound Healing DelayedArmsILP100-Topical (emilimogene sigulactibac) 5x10^7 CFU/cm^2, ILP100-Topical (emilimogene sigulactibac) 1x10^9 CFU/cm^2, Placebo
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Developing anACS pharmacology & translational science · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Antimicrobial activity of dietary supplements based on bacterial lysate ofFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Emelie ÖhnstedtDepartment of Medical Cell Biology, Uppsala University, 751 23 Uppsala, Sweden.
Hava Lofton TomeniusDepartment of Medical Cell Biology, Uppsala University, 751 23 Uppsala, Sweden.
Peter FrankIlya Pharma AB, Dag Hammarskjölds Väg, 752 37 Uppsala, Sweden.
Stefan RoosDepartment of Molecular Sciences, Swedish University of Agricultural Sciences, 756 51 Uppsala, Sweden.
Evelina VågesjöDepartment of Medical Cell Biology, Uppsala University, 751 23 Uppsala, Sweden.ORCID 0000-0002-4254-6875
Mia PhillipsonDepartment of Medical Cell Biology, Uppsala University, 751 23 Uppsala, Sweden.
Uppsala University · SEIlya Pharma (Sweden) · SESwedish University of Agricultural Sciences · SE

Funding

European Institute of Innovation and Technology (EIT) Health "EIT Health Head Start and Proof-of-Concept Projects" 2016H2020 804438Knut and Alice Wallenberg Foundation No numberSwedish Research Council 2018-02552_VRVINNOVA 2017-03573
6 · The paper itself

Abstract

Non-healing wounds are a growing medical problem and result in considerable suffering. The lack of pharmaceutical treatment options reflects the multistep wound healing process, and the complexity of both translation and assessment of treatment efficacy. We previously demonstrated accelerated healing of full-thickness wounds in mice following topical application of the probiotic bacteria

Indexed as

active wound carechemokinesLimosilactobacillus reuterithree-dimensional imagingtopicalwound measurement

Identifiers

PMID35213962
PMCPMC8876577
OpenAlexW4206564415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.